Concepedia

Cathy J. Kieras

CJ

Statistics

Publications

4

Citations

177

H-Index

4

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Cathy J. Kieras is an author at Bristol-Myers Squibb (United States) specializing in cell signaling, signal transduction, and thrombosis.

Top concepts

Publications per year

2002–2008

4

Publications

4

The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression

Catherine R. Burton, Jere E. Meredith, Donna M. Barten et al. · Journal of Biological Chemistry · 2008 · 66 citations · Full text

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

Jeffrey T. Billheimer, Ira B. Dicker, Richard Wynn et al. · Blood · 2002 · 59 citations · Full text

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia

Dietmar Seiffert, Andrew M. Stern, William F. Ebling et al. · Blood · 2002 · 34 citations · Full text

Regulation of clot retraction by glycoprotein IIb/IIIa antagonists

Dietmar Seiffert, Donna L. Pedicord, Cathy J. Kieras et al. · Thrombosis Research · 2002 · 18 citations

, , +6

1–4 of 4